Pear Therapeutics Stock
Digital Therapeutics Platform
Sign up today and learn more about Pear Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.
Chief Executive Officer
Chief Financial Officer